FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068100065> ?p ?o ?g. }

• W2068100065 endingPage "2026" @default.
• W2068100065 startingPage "2020" @default.
• W2068100065 abstract "Multiple endocrine and metabolic consequences of human immunodeficiency virus (HIV) infection exist that may contribute to bone loss in men with the acquired immune deficiency syndrome (AIDS) wasting syndrome. Recent studies suggest that anabolic strategies can increase lean body mass in men with AIDS wasting. Prior studies have not examined the effects of anabolic agents on bone mineral density (BMD) or bone turnover in these men. To determine the effects of testosterone and progressive resistance training on BMD and bone turnover in eugonadal men with AIDS wasting, we randomly assigned 54 eugonadal men with AIDS wasting (weight < 90% IBW or weight loss >10% from preillness baseline) to receive either testosterone enanthate (200 mg/week, im) or placebo and to progressive resistance training (3 times/week) or no training in a 2 x 2 factorial study design for 3 months. The BMD of the lumbar spine, proximal femur, and total body; lean body mass; and fat mass were measured by dual energy x-ray absorptiometry. Total body scans were repeated after 12 weeks of therapy. Baseline bone turnover and BMD were compared with those in 35 age-matched healthy non-HIV-infected control subjects. Compared with controls, lumbar spine BMD (1.021 +/- 0.018 vs. 1.084 +/- 0.025 g/cm(2); P = 0.04) and total hip BMD (0.951 +/- 0.017 vs. 1.070 +/- 0.019 g/cm(2); P < 0.0001) were reduced in men with AIDS wasting. T-scores were lower in men with AIDS wasting at the lumbar spine (-0.62 +/- 0.17 vs. -0.07 +/- 0.23, P = 0.05) and total hip (-0.65 +/- 0.11 vs. +0.20 +/- 0.014, P < 0.0001). Total hip T scores were less than -1.0 in 33% of men with AIDS wasting. Neither the use of protease inhibitors nor the duration of protease inhibitors use correlated with BMD. Serum osteocalcin levels were lower (3.63 +/- 0.29 vs. 4.54 +/- 0.31 nmol/L; P < 0.04) and urinary N-telopeptide excretion was higher (45.4 +/- 4.5 vs. 26.8 +/- 3.0 nmol BCE/mmol creatinine; P = 0.004) in men with AIDS wasting than in controls. Lumbar spine BMD, as assessed on regional total body dual energy x-ray absorptiometry scan, increased over the 12-week treatment period in response to testosterone (+2.4 +/- 1.3 vs. -1.3 +/- 1.0%, testosterone vs. placebo, respectively; P = 0.02), but not in response to training (+0.8 +/- 1.0 vs. +0.4 +/- 1.3%, training vs. no training; P = 0.70). Lumbar spine and total hip BMD are reduced in eugonadal men with AIDS wasting. Biochemical markers of bone turnover suggest that bone formation and bone resorption are uncoupled in these men. Testosterone administration, but not resistance training, over 3 months increases lumbar spine BMD in eugonadal men with AIDS wasting." @default.
• W2068100065 created "2016-06-24" @default.
• W2068100065 creator A5013380382 @default.
• W2068100065 creator A5034090492 @default.
• W2068100065 creator A5047688241 @default.
• W2068100065 creator A5063043469 @default.
• W2068100065 date "2001-05-01" @default.
• W2068100065 modified "2023-10-01" @default.
• W2068100065 title "Osteopenia in Eugonadal Men with Acquired Immune Deficiency Syndrome Wasting Syndrome1" @default.
• W2068100065 cites W1937757791 @default.
• W2068100065 cites W1964626005 @default.
• W2068100065 cites W1980227876 @default.
• W2068100065 cites W1986316445 @default.
• W2068100065 cites W2013160851 @default.
• W2068100065 cites W2015321713 @default.
• W2068100065 cites W2020157457 @default.
• W2068100065 cites W2021163625 @default.
• W2068100065 cites W2034069919 @default.
• W2068100065 cites W2053216237 @default.
• W2068100065 cites W2053232341 @default.
• W2068100065 cites W2054906515 @default.
• W2068100065 cites W2075416173 @default.
• W2068100065 cites W2079360448 @default.
• W2068100065 cites W2141281391 @default.
• W2068100065 cites W2143878458 @default.
• W2068100065 cites W2147956163 @default.
• W2068100065 cites W2155896219 @default.
• W2068100065 doi "https://doi.org/10.1210/jcem.86.5.7515" @default.
• W2068100065 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11344201" @default.
• W2068100065 hasPublicationYear "2001" @default.
• W2068100065 type Work @default.
• W2068100065 sameAs 2068100065 @default.
• W2068100065 citedByCount "44" @default.
• W2068100065 countsByYear W20681000652012 @default.
• W2068100065 countsByYear W20681000652014 @default.
• W2068100065 countsByYear W20681000652015 @default.
• W2068100065 countsByYear W20681000652016 @default.
• W2068100065 countsByYear W20681000652017 @default.
• W2068100065 countsByYear W20681000652018 @default.
• W2068100065 countsByYear W20681000652019 @default.
• W2068100065 countsByYear W20681000652020 @default.
• W2068100065 crossrefType "journal-article" @default.
• W2068100065 hasAuthorship W2068100065A5013380382 @default.
• W2068100065 hasAuthorship W2068100065A5034090492 @default.
• W2068100065 hasAuthorship W2068100065A5047688241 @default.
• W2068100065 hasAuthorship W2068100065A5063043469 @default.
• W2068100065 hasBestOaLocation W20681000651 @default.
• W2068100065 hasConcept C1008401 @default.
• W2068100065 hasConcept C120863210 @default.
• W2068100065 hasConcept C126322002 @default.
• W2068100065 hasConcept C134018914 @default.
• W2068100065 hasConcept C147583825 @default.
• W2068100065 hasConcept C170033053 @default.
• W2068100065 hasConcept C2776541429 @default.
• W2068100065 hasConcept C2776886416 @default.
• W2068100065 hasConcept C2777083390 @default.
• W2068100065 hasConcept C2779279991 @default.
• W2068100065 hasConcept C2779329777 @default.
• W2068100065 hasConcept C2779764123 @default.
• W2068100065 hasConcept C2911126609 @default.
• W2068100065 hasConcept C71924100 @default.
• W2068100065 hasConceptScore W2068100065C1008401 @default.
• W2068100065 hasConceptScore W2068100065C120863210 @default.
• W2068100065 hasConceptScore W2068100065C126322002 @default.
• W2068100065 hasConceptScore W2068100065C134018914 @default.
• W2068100065 hasConceptScore W2068100065C147583825 @default.
• W2068100065 hasConceptScore W2068100065C170033053 @default.
• W2068100065 hasConceptScore W2068100065C2776541429 @default.
• W2068100065 hasConceptScore W2068100065C2776886416 @default.
• W2068100065 hasConceptScore W2068100065C2777083390 @default.
• W2068100065 hasConceptScore W2068100065C2779279991 @default.
• W2068100065 hasConceptScore W2068100065C2779329777 @default.
• W2068100065 hasConceptScore W2068100065C2779764123 @default.
• W2068100065 hasConceptScore W2068100065C2911126609 @default.
• W2068100065 hasConceptScore W2068100065C71924100 @default.
• W2068100065 hasIssue "5" @default.
• W2068100065 hasLocation W20681000651 @default.
• W2068100065 hasLocation W20681000652 @default.
• W2068100065 hasOpenAccess W2068100065 @default.
• W2068100065 hasPrimaryLocation W20681000651 @default.
• W2068100065 hasRelatedWork W164830215 @default.
• W2068100065 hasRelatedWork W1786411514 @default.
• W2068100065 hasRelatedWork W2004751374 @default.
• W2068100065 hasRelatedWork W2068100065 @default.
• W2068100065 hasRelatedWork W2110400973 @default.
• W2068100065 hasRelatedWork W2341287688 @default.
• W2068100065 hasRelatedWork W2473844262 @default.
• W2068100065 hasRelatedWork W3030667799 @default.
• W2068100065 hasRelatedWork W4232948481 @default.
• W2068100065 hasRelatedWork W2081521625 @default.
• W2068100065 hasVolume "86" @default.
• W2068100065 isParatext "false" @default.
• W2068100065 isRetracted "false" @default.
• W2068100065 magId "2068100065" @default.
• W2068100065 workType "article" @default.